Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
230 hedge funds and large institutions have $3.44B invested in Axonics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 94 increasing their positions, 57 reducing their positions, and 22 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
159% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 22
65% more repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 57
30% more capital invested
Capital invested by funds: $2.65B → $3.44B (+$787M)
24% more call options, than puts
Call options by funds: $1.95M | Put options by funds: $1.57M
17% more funds holding
Funds holding: 196 → 230 (+34)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$68.4M |
| 2 |
FAM
Fred Alger Management
New York
|
+$66.4M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$44.8M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$42.2M |
| 5 |
JP Morgan Chase
New York
|
+$24.9M |
Top Sellers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$33.9M |
| 2 |
Millennium Management
New York
|
-$30.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$28.2M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$24.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$21.8M |
AXNX Hedge Fund Activity: Q3 2022 in Review
230 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q3 2022, worth a combined $3.44B — up 30% from $2.65B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new AXNX positions and 22 closed out — a net gain of 35 holders — while 94 added to existing stakes and 57 trimmed.
The largest buyer was Vanguard Group, adding an estimated $68.4M. The largest seller was Credit Suisse, cutting an estimated $33.9M.
- 230 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q3 2022, up from 196 in Q2 2022.
- Funds reported $3.44B of Axonics, Inc. Common Stock stock for Q3 2022, up 30% quarter-over-quarter.
- 57 funds opened new Axonics, Inc. Common Stock positions in Q3 2022 and 22 closed out, a net change of +35 holders.
- The largest Axonics, Inc. Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $68.4M added.
- The largest Axonics, Inc. Common Stock seller in Q3 2022 was Credit Suisse, an estimated $33.9M sold.
Based on aggregated 13F filings for Q3 2022.